We recently concluded a highly fruitful visit and technology transfer session between CytoVision and KFBIO, marking an important milestone in our shared mission to advance digital pathology across the region.
During this engagement, Cytovisionโs biomedical engineering team received first-hand exposure, in-depth technical training, and hands-on introduction to KFBioโs state-of-the-art digital pathology and whole slide imaging platforms. This direct knowledge transfer ensures not only operational excellence, but also long-term sustainability in deploying advanced digital pathology solutions.
๐ฌ ๐ช๐ต๐ ๐๐ต๐ถ๐ ๐บ๐ฎ๐๐๐ฒ๐ฟ๐
Digital pathology is rapidly becoming a cornerstone of modern diagnostics, research, education, and AI-driven workflowsโenabling faster turnaround times, remote collaboration, scalable expertise, and the foundation for computational pathology and precision medicine.
๐ก ๐ฆ๐๐ฟ๐ฒ๐ป๐ด๐๐ต๐ ๐๐ต๐ฎ๐ ๐บ๐ฎ๐ธ๐ฒ ๐๐ต๐ถ๐ ๐ฐ๐ผ๐น๐น๐ฎ๐ฏ๐ผ๐ฟ๐ฎ๐๐ถ๐ผ๐ป ๐ฝ๐ผ๐๐ฒ๐ฟ๐ณ๐๐น
KFBio brings deep expertise in high-throughput, high-resolution whole slide imaging systems and AI-ready digital pathology technologies, trusted by leading institutions globally.
Cytovision contributes strong regional implementation capabilities, clinical and research domain knowledge, and hands-on technical excellence in deploying, validating, and supporting digital pathology platforms across Southeast Asia.
๐ ๐๐ผ๐ผ๐ธ๐ถ๐ป๐ด ๐ฎ๐ต๐ฒ๐ฎ๐ฑ
This visit goes beyond trainingโit represents a strategic alignment to accelerate the adoption of robust, scalable, and future-ready digital pathology solutions in Southeast Asia, supporting clinical services, research innovation, education, and AI development.
We look forward to translating this collaboration into real-world impact for laboratories, researchers, and healthcare systems across the region.
